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Background: Urinary tract infections (UTIs) are among the most common bacterial infections. In uncomplicated cases the infection is 
easily treated with a course of antibiotic, but there is increased resistance to many of these antibiotics. 
Objective: To determine the profile of UTI among patients using National Hospital Abuja and the antibiotic susceptibility profile of 
isolated uropathogens. 
Methods: This prospective study was carried out at the department of Medical Microbiology of National Hospital, Abuja over a period 
of three years (January 2010 – December 2012). A total of 6763 urine samples were analyzed for age, gender, distribution, yield and 
antibiotics sensitivity. 
Results: Of 6763 urine samples, 885 (13.1%) yielded uropathogens, with the highest percentage yield in the below one year and above 57 
years age groups. The mean age was 33.9 years and modal group was 25 -32 years.  The most common isolates were Escherichia coli 323 
(37%) and Klebsiella spp 202 (25%). Although more infections occurred in outpatients than inpatients, the rate was more with 
inpatients (36% vs 11%). 97% of Klebsiella spp, 89% of E coli and 83% of P.aeruginosa were sensitive to imipenem, while their 
respective sensitivities to amikacin were 65%, 98% and 96% Most isolates showed high levels of resistance to many other antibiotics 
tested. 
Conclusion: High levels of resistance exist among uropathogens in our study area. This calls for regular surveillance and improved 
antibiotic stewardship. 
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INTRODUCTION 
Urinary tract infection or UTI is said to exist when a 
significant number of microorganisms, usually greater 
than 105 cells per millilitre of urine, are detected in 
properly collected mid-stream “ clean catch”urine(1,2). 
The gold standard for diagnosis is the detection and 
identification of the causative pathogen in the urine(3). 
UTI is one of the most common infections to plague man 
worldwide(4,5). Over 150 million people worldwide 
experience an episode yearly, costing the world economy 
over 6 billion US dollars in treatment and workloss(6). In 
the USA alone this result in over 8 million visits to the 
physician office and 1.5 million emergency room visits 
with about 300,000 admissions(7,8).  
The common etiologic agents of UTI include 
enterobacteriacae like E. coli and Klebsiella spp, as well 
as Gram positive organisms like Staphylococci and 
enterococci(9-11) and Candida albicans in patients with 
underlying physiological debilitation(12). Studies carried 
out in Enugu, Yola, Zaria and Ife(13-16) show that these 
are the same etiological agents isolated in Nigeria. 
UTI is commonly treated with oral antibiotics like 
amoxicillin-clavulante, nitrofurantoin, cephalosporins, 
fluoroquinolones and trimethropin-
sulfamethoxazole(17). However, available data indicate 
that Nigeria has isolates with high levels of resistance(18-
21), thus underscoring the need for regular institutional, 
regional and national surveillance in order to optimize 
care. The study was designed to profile UTIs as seen at 
the National Hospital Abuja in order to provide 
guidelines for optimization of antibiotics treatment of 
UTIs. 
METHOD 
The biodata for this study namely, age, gender, ward and 
clinic, were extracted from the request forms of the 
patients sent to the laboratory for UTI investigations 
from January 1, 2010 to December 31, 2012. Samples with 
incomplete information were excluded from the study. 
All samples were processed in the Medical Microbiology 
laboratory of National Hospital, Abuja using standard 
procedures(22,23). Briefly, samples were examined 
macroscopically and microscopically, and thereafter 
inoculated onto CLED and blood agar media, and 
incubated in air at 35-36oC for 16-24 hours. Significant 
isolates were identified biochemically and antibiotic 
sensitivity performed by disc method using modified 
Kirby Bauer  method. Data were analyzed using 
Microsoft excel 2007 software.  
 
RESULTS 
A total of 14700 urine samples were sent to the Medical 
microbiology department for urine microscopy, culture 
and sensitivity within the three year study period. 6763 
(46%) met the inclusion criteria. 4125 (61%) were from 
females while 2638 (39%) were from males. There were 
5380 (80%) adult samples and 1383 (20%) from children. 
6215 (92%) samples were from outpatients while 548 (8%) 





TABLE 1: OUTPATIENT AND INPATIENT DISTRIBUTION 
OF PATIENTS 
Source Total samples  Positive 
samples  
Outpatients  6215 (92%) 689 (11%) 
Inpatients  548 (8%) 196 (36%) 
Total  6763 (100%) 885 (13%) 
 
885 (13%) specimens yielded significant growth. The 
yield from female samples was 14% compared to 12% 
from males, while it was 13.6% among adults and 11% 
among children. 36% and 11% of in-patient and 
outpatient samples respectively yielded significant 
growth (table 2). 
 


















0 – 1 40 18(45) 32 15(50) 72 33(46) 
2 – 8 391 26(7) 399 41(11) 808 67(8) 
9 – 16 216 20(9) 337 32(10) 553 52(9) 
17 – 24 66 10(15) 402 50(12) 468 60(13) 
25 – 32 930 60(7) 1997 200(10) 2927 260(9) 
33 – 40 213 26(12) 438 70(16) 651 96(15) 
41- 48 266 25(9) 237 50(22) 503 75(15) 
49 – 56 118 21(18) 119 30(25) 237 51(22) 
57 – 64 104 22(21) 86 38(44) 190 60(32) 
>64 222 78(35) 182 53(29) 404 131(32) 
Total 2566 306 (12) 4197 579 (14) 6763 885 (13) 
 
The age group with the highest yield was the neonate 
(46%) and the above 64 year old with 32.4%, while the 
age group of 25-32 years had the lowest.   
The most frequently isolated pathogen was E. coli 37%, 
followed by Klebsiella spp 25%, P. aeruginosa 8.4%, 
Proteus spp 7.5%, S. aureus 6.8%, Enteroccocus spp 6.2% 
and Candida spp at 5.3% (table 3). 50% of all isolates 
from ICU were Candida spp.  
 
TABLE 3: FREQUENCY OF ISOLATES 
Isolates Number (%) 
E. coli 323 (37%) 
Klebsiella spp           202(25%) 
P. aeruginosa 75 (8.4%) 
Proteus spp 67 (7.5%) 
S. aureus 60 (6.8%) 
Enterococcus faecalis 55 (6.2%) 
Candida spp 47 (5.3%) 
Others 56 (6.3%) 
Total 885 (100%) 
 
97% of Klebsiella spp, 89% of E coli and 83% of 
P. aeruginosa were sensitive to imipenem, 
while their respective sensitivities to amikacin 
were 65%, 98% and 96% (table 4). Sensitivity of 
P aeruginosa to ceftazidime, ciprofloxacin and 
gentamicin were 33%, 44% and 24% 
respectively. 81% of S. aureus isolates were 
sensitive to nitofurantoin, 80% to amikacin, 
73% to amoxicillin/clavulanate and 63% to 
ciprofloxacin. 83% of all tested isolates of E. 
faecalis were sensitive to 
amoxicillin/clavulanate, while 67% and 66% 
















Proteus spp E. faecalis S. aureus 
T (%S) T (%S) T (%S) T (%S) T (%S) T (%S) 
Ampicillin 31(1) - - 3(0) 3(33) 10(40) 
Amoxicillin/ 
Clavulante 
185(27) 71(25) - 48(19) 24(83) 26(73) 
Ceftriaxone 176(67) 54(48) - 3(0) 6(67) 15(60) 
Ceftazidime - 66(55) 48(33) 45(60) - - 
Ciprofloxacin 103(53) 28(43) 41(44) 12(25) 6(17) 19(63) 
Imipenem 45(89) 37(97) 35(83) - 4(100) - 
Nitrofurantoin 265(79) 98(40) - 60(45) 29(66) 43(81) 
Gentamicin 143(43) 46(39 42(24 21(43) 5(40) 25(48) 
Amikacin 84(98) 62(65) 25(96) 54(67) 14(21) 20(80) 
T =Total tested, %S= percentage sensitive  
 
DISCUSSION 
The prevalence rate of UTI from this study was 13%, 
which is lower than figures from previous studies in Yola 
(67.2%), Enugu (77.9%), South Africa (51%) and India ( 
27%)(14,15,24,25). It is however, higher than the figure 
for pregnant women in Ghana 9.5%26. The variation in 
rates may be partly explained by the differences in study 
populations and in the criteria used by centres in 
selecting urine samples for culture. Some centers exclude 
samples from patients clinically diagnosed with UTI or 
previous antibiotic use(27). The taking of antibiotics prior 
to presentation at the hospital maybe a key factor in 
bacterial yield(28).These factors were not considered in 
this study. 
Most of the requests for UTI investigation came from the 
outpatient department, which sees most of the cases 
coming in directly from the community, and by 
extension serves as the clearing house for the specialists’ 
clinics/units. An uncomplicated UTI is unlikely to be 
admitted into the wards. This finding is consistent with 
findings in studies from Botswana and the United 
States(29,30) . However, the yield from inpatient samples 
was more than three times that of outpatients. This may 
be due to primary diseases of the patients, some of which 
compromise the immunity of the patients and the use of 
invasive devices such as urinary catheters in the hospital 
setting(8,9,11). 
The finding that UTI was more frequent in women than 
men is in agreement with previous studies(14,24,25,31). 
However, the yields from samples were not markedly 
different in the two groups (14% vs 12%). The higher 
frequency in females has been attributed to the shorter 
female urethra and the proximity of this to the 
gastrointestinal outlet, hence making it easier for enteric 
flora to colonize this area(32,33). Other contributory 
factors may include the use of contraceptives, childbirth 
and menopause(34,35). 
The incidence of UTI was highest among infants, and 
thereafter dropped sharply from age two and maintained 
a rise until age 25-32 when it dropped slightly before 
maintaining the rise again. Previous studies have shown 
the incidence of UTI in infants to range from 0.7 – 7% 
with girls having lower rates than boys(4,36). The very 
high incidence recorded in this study likely represent 
contaminations and poor handling of the samples. 
Further study will be required to determine the true 
incidence of UTI in our environment. The age group with 
the highest sample is paradoxically among the group 
with least incidence.  This is a very sexually active age 
group, and the age that most commonly abuse 
antibiotics(37), thus explaining the relatively low yield of 
samples. The high incidence in both sexes with 
advancing age has been attributed to the presence of a 
number of risk factors such as prostatic enlargement in 
males, diabetes mellitus, reduced ambulation, 
osteoporosis, interventional instrumentations like 
catheterization and weak bladder sphincter(12). 
Gram negative Enterobacteriacae led by E coli and 
Klebsiella pneumoniae dominated the uropathogens seen 
in this study, similar to results of other studies 
elsewhere(14,15,38). S. aureus and enterococcus faecalis 
were the two Gram positive isolates and made up only 
13% of all isolates. Previous studies have found 
Staphylococcus as an increasing cause of UTI, and 
attributed this to increased instrumentation like bladder 
catheterization(11,12,39). The rate of candiduria found in 
this study is of concern, considering that previous studies 
in Israel and Italy found rates ranging from 0.14-
0.77%(40,41). Although the 5.3% rate in this study is 
lower than that found in a European study (9.4%)(42), we 
did not have data to differentiate between true infection 
and contamination.  
The majority of isolates showed resistance to drugs 
commonly used to treat UTIs. Imipenem was broadly the 
most sensitive drug, followed by amikacin, and 
ceftriaxone, and these are not drugs often deployed as 
first line in the treatment of uncomplicated UTI. 
Although different studies in different parts of the world 
and in different parts of the same country found different 
resistance rates to different drugs over time(14-17,43-50)  
it is important that emphasis be paid to local resistance 
patterns as these have the greatest impact on care. These 
variations in susceptibility may be due to the prescription 
habits in different localities as inappropriate exposure to 
antibiotics drives development of resistance. From the 
results of this study it is certain that choosing drugs for 
empiric treatment will be challenging as no single 




that. This reinforces the need for mandatory urine culture 
for all suspected UTIs to properly guide therapy. 
In conclusion, E. coli remains the most frequent isolate 
from our environment causing UTI. However this 
pathogen, as well as other enterobacteriaceae especially 
K. pneumoniae, isshowing increased resistance to beta-
lactam, aminoglycoside and fluoroquinolones. Regular 
antibiotic surveillance and practice of antibiotic 
stewardship will help stem the tide of resistance and 






1. Sobel JD, Kaye D. Urinary tract infections. In: 
Mandell GL, Benneth JE, Dolin R(eds.) Mandell , 
Douglas and Benneth’s principle and practice of 
infectious disease. 7th ed. Philadelphia, PN: 
Elsevier Churchill Livingstone; 2010. 957-86. 
2. Williams DN. Urinary Tract Infection: Emerging 
insights into appropriate Management. Postgrad 
Med 1996; 99(4):189-99. 
3. Schmiemann G, Kniehl E, Gebhardt K, Matejczyk 
MM, Hummers-Pradier E. The Diagnosis of 
Urinary Tract Infection: A Systematic Review. 
Deutsches Ärzteblatt Int 2010;107(21):361–7. 
4. Chang SL, Shortliffe LD. Pediatric urinary tract 
infections. Pediatr Clin North Am 2006;53:379-
400. 
5. Kucheria R, Dasgupta P, Sacks SH, Khan MS, 
Sheerin NS. Urinary tract infections: new 
insights into a common problem. Postgrad Med J  
2005;81:83-6. 
6. Gupta K. Increasing antimicrobial resistance and 
the management of uncomplicated community 
acquired urinary tract infections. J Antimicrob 
Agents 2001;135:41-50. 
7. Stamm WE, Hooton TM. Management of urinary 
tract infections in adults. N Engl J Med 
1993;329:1328-34. 
8. Orenstein R, Wong ES. Urinary Tract Infections 
in Adults. Am Fam Physician  1999;59(5):1225-
1234. 
9. Litwin MS, Saigal CS, Yano EM, Avila C, 
Geschwind SA, Hanley JM, et al. Urologic 
Diseases in America Project: analytical methods 
and principal findings. J Urol 2005;173:933-7. 
10. Ronald A. The etiology of urinary tract 
infection: traditional and emerging 
pathogens.Dis Mon 2003;49(2):71-82.  
11. Foxman B. Epidemiology of urinary tract 
infections: incidence, morbidity, and economic 
costs. Dis Mon 2003;49:53-70. 
12. Moore KN, Day RA, Albers M. Pathogenesis of 
urinary tract infections: a review. J Clin Nurs  
2002;11(5):568-74. 
13.  Mbata T. Prevalence And Antibiogram Of 
Urinary Tract Infections Among Prison 
Inmates In Nigeria. The Internet Journal  
of Microbiology  2007;3(2). DOI 
10.5580/557 (accessed 20 may 2013). 
14. El-Mahmood MA. Antimicrobial susceptibility 
pattern of pathogenic bacteria causing urinary 
tract infection in a specialist hospital in Yola, 
Adamawa state. Journal of Clinical Medicine and 
Research 2009;1(1):001-008. 
15. Ehinmidu JO. Antibiotics susceptibility patterns 
of urine bacterial isolates in Zaria, Nigeria. Trop 
J Pharm Res 2003;2(2):223-8. 
16. Ako-Nai AK, Kassim OO, Adeniran MO, Taiwo 
O. A study of urinary tract infections at Ile-Ife, 
Nigeria. East Afr Med J 1993;70(1):10-14. 
17. Zalmanovici Trestioreanu A, Green H, Paul M, 
Yaphe J, Leibovici L. Antimicrobial agents for 
treating uncomplicated urinary tract infection in 
women.In Zalmanovici Trestioreanu Anca 
"Cochrane Database of Systematic Reviews". 
Cochrane Database Syst Rev  
2010;10(10):CD007182.  
18. Ozumba UC. Antimicrobial resistance problems 
in a university hospital. J Natl Med 
Assoc2005;97(12):1714–18.  
19. Aboderin OA, Abdu AR, Odetoyin BW, 
Lamikanra A. Antimicrobial resistance in 
escherichia coli strains from urinary tract 
infections.J Natl Med Assoc2009;101:1268–1273. 
20. Dada-Adegbola HO, Muili KA. Antibiotic 
susceptibility pattern of urinary tract pathogens 
in Ibadan, Nigeria.Afr J Med MedSci 
2010;39(3):173-9.  
21. Akujobi C N, Ewuru CP. Detection of extended 
spectrum beta-lactamases in gram negative 
bacilli from clinical specimens in a teaching 
hospital in South eastern Nigeria. Niger Med J 
2010;51:141-6. 
22. Holt JG, Krieg NR, Sneath PHA, Stanley JT, 
Williams ST. Bergey's manual of Systematic 
Bacteriology . 9th ed. Baltimore, MD: Williams 
and Wilkins company; 1994; p.786. 
23. Bauer AW, Kirby WM, Sherris JC, Jurck M. 
Antibiotic susceptibility testing by a standard 
single disc method. Am J Clin. Path 1996;451:493-
6. 
24. Habte TM, Dube S, Ismail N, Hoosen AA. 
Hospital and community isolates of 
uropathogens at a tertiary hospital in South 
Africa.S Afr Med J  2009;99(8):584-7.  
25. Ahmad S. Pattern of urinary tract infection in 
Kashmir and antimicrobial susceptibility. 
Bangladesh Med Res Counc Bull  2012;38:79-83.  
26. Obirikorang C, Quaye L, Bio FY, Amidu N, 
Acheampong I, Addo K. Asymptomatic 
Bacteriuria among Pregnant Women Attending 
Ante-natal Clinic at the University Hospital, 





27. Kolawole AS, Kolawole OM, Kandaki-Olukemi 
Y, Babatunde SK, Durowade KA, Kolawole CF. 
Prevalence of urinary tract infections (UTI) 
among patients attending Dalhatu Araf 
Specialist Hospital, Lafia, Nasarawa State, 
Nigeria. Int. J. Med. Sci  2009;1(1):163-67. 
28. Okeke IN, Lamikanra A, Edelman R. 
Socioeconomic and behavioral factors leading to 
acquired bacterial resistance to antibiotics in 
developing countries. Emerg Infect Dis 
1999;5(1):18-27. 
29. Renuart AJ. Microbiology of Urinary Tract 
Infections in Gaborone, Botswana. PLoS One. 
2013;8(3): e57776. 
30. Doyle B, Mawji Z, Horgan M, Stillman P, 
Rinehart A, Bailey J, Mullin E Jr. Decreasing 
nosocomial urinary tract infections in a large 
academic community hospital. Lippincotts Case 
Manag 2001;6(3):127-36. 
31. Randrianirina F, Soares JL, Carod JF, Ratsima E, 
Thonnier V, Combe P, Grosjean P, Talarmin AJ. 
Antimicrobial resistance among uropathogens 
that cause community acquired urinary tract 
infections in Antananarivo, Madagascar. 
AntimicrobChemother 2007;59(2):309-12.  
32. Dai B, Liu Y, Jia J, Mei C. Long-term antibiotics 
for the prevention of recurrent urinary tract 
infection in children: a systematic review and 
meta-analysis. Archives of Disease in Childhood  
2010;95(7):499–508. 
33. Salvatore S, Cattoni E, Siesto G, Serati M, Sorice 
P, Torella M. Urinary tract infections in women. 
European journal of obstetrics, gynecology, and 
reproductive biology2011;156(2):131–6. 
34. Phipps S, Lim YN, McClinton S, Barry C, Rane 
A, N'Dow J. Short term urinary catheter policies 
following urogenital surgery in adults. In 
Phipps, Simon. "Cochrane Database of 
Systematic Reviews". Cochrane Database Syst Rev  
2006;(2): CD004374. 
35. Dielubanza EJ, Schaeffer AJ. Urinary tract 
infections in women. The Medical clinics of North 
America2011;95(1):27–41. 
36. Shaikh N, Morone NE, Bost JE, Farell MH. 
Prevalence of urinary tract infection in 
childhood; A metanalysis. Pediatr Infect Dis J 
2008;27:302-8. 
37. Eng JV, Marcus R, Besser RE. Consumer 
attitudes and use of antibiotics. Emerg Infect Dis 
2003 September;9(9):1128-35. 
38. Pondei K, Oladapo O, Onyaye E, Olowu K. 
Anti-microbial susceptibility pattern of micro-
organisms associated with urinary tract 
infections in a tertiary health institution in the 
Niger Delta Region of Nigeria. African Journal of 
Microbiology Research 2012;6(23):4976-8. 
39. Muder RR, Brennen C, Rihs JD, Wagener MM, 
Obman A, Stout JE, Yu VL. Isolation of 
Staphylococcus aureus from the urinary tract: 
association of isolation with symptomatic 
urinary tract infection and subsequent 
staphylococcal bacteremia.Clin Infect Dis 
2006;42(1):46-50.  
40. Colodner R, Nuri Y, Chazan B, Ra R. 
Community-acquired and hospital-acquired 
candiduria: comparison of prevalence and 
clinical characteristics. Eur J Clin Microbiol Infect 
Dis 2008;27:301-5. 
41. Navarro EE, Almario JS, King C, Bacher J, Pizzo 
PA, Walsh TJ. Detection of Candida casts in 
experimental renal candidiasis: implications for 
the diagnosis and pathogenesis of upper urinary 
tract infection. J Med Vet Mycol 1994;32:415–26. 
42. Alvarez-Lerma, F, Nolla-Salas J, Leon C, 
Palomar M, Jorda R, Carrasco N, Bobillo F. 
Candiduria in critically ill patients admitted to 
intensive care medical units. Intensive Care Med 
2003;29:1069-76. 
43. Ghorbani A, Ehsanpour A, Roshanzamir N, 
Omidvar B. Alterations in antibiotic 
susceptibility of urinary tract infection 
pathogens. J Nephropathology 2012;1(1):43-48.  
44. Orett FA. Urinary tract infections in a rural 
community in South Trinidad. Saudi Med J 
2001;22(6): 537-40. 
45. Raza S, Pandey S, Bhatt C . Microbiological 
Analysis of the Urine Isolates in Kathmandu 
Medical College Teaching Hospital, 
Kathmandu, Nepal. Kathmandu Univ Med J 
2011;9(36):295-7. 
46. Akujobi CN. Antimicrobial susceptibility 
pattern of Klebsiella species from Ebonyi State 
University Teaching Hospital Abakaliki, 
Nigeria. Niger J ClinPract2005;8(2):90-3. 
47. Fadeyi A, Akanbi AA II, Nwabuisi C, Onile BA. 
Antibiotic disc sensitivity pattern of 
pseudomonas aeruginosa isolates obtained from 
clinical specimens in Ilorin, Nigeria.Afr J Med 
Med Sci 2005;34(3):303-6.  
48. Jombo GTA, Jonah P, Ayeni JA. Multidrug 
resistant Pseudomonas aeruginosa in 
contemporary medical practice: findings from 
urinary isolates at a Nigerian university 
teaching hospital.Nigerian Journal of Physiological 
Sciences 2008;23(1-2): 105-9. 
49. Oluremi BB, Idowu AO,Olaniyi JF. Antibiotic 
susceptibility of common bacterial pathogens in 
urinary tract infections in a Teaching hospital in 
Southwestern Nigeria. African Journal of 
Microbiology Research 2011; 5(22):3658-63.  
50. Taconelli E, Cataldo MA. Vancomycin resistant 
enterococci (VRE): transmission and control. Int 
J Antimicrob Agents 2008;31:99-106. 
173 
